Leukocyte chemoattractants regulate many leukocyte functions, including leukocyte chemotaxis, via the Rho family of small GTPases that include RhoA, Cdc42, and Rac [1-4]. Previous work has revealed mechanisms by which chemoattractants regulate RhoA and Cdc42 in mouse neutrophils [5] [6] [7] [8] , but the mechanisms for regulation of Rac remain unclear even though Rac is important for neutrophil functions [9-13]. Here, we characterized P-Rex1, a G␤␥ and PIP 3 -regulated guanine nucleotide exchange factor that was initially identified as a Rac activator in response to chemoattractants [14], for its roles in the regulation of Rac activity and neutrophil functions. We generated a mouse line in which the P-Rex1 gene is disrupted and found that P-Rex1 deficiency did not significantly affect Rac1 activation but diminished Rac2 activation in response to a chemoattractant fMLP in mouse neutrophils. This preference for Rac2 may partially result from the apparent higher affinity of P-Rex1 for Rac2 than for Rac1 because P-Rex1 was more readily immunoprecipitated with Rac2 S17N than Rac1 S17N . In addition, P-Rex1 deficiency significantly attenuated fMLP-induced F actin formation and superoxide production without affecting LPS-or PMAinduced production. Furthermore, P-Rex1 deficiency caused a chemotactic defect that is primarily attributed to a reduction in the migration rate rather than directionality.
Results and Discussion

P-Rex1-Deficient Mice
To investigate the in vivo significance of P-Rex1 in its regulation of Rac activity and neutrophil functions, we generated a P-Rex1 mutant mouse line by using the conventional gene-targeting approach. The part of the P-Rex1 gene that contains exon 4 was replaced by a neomycin-resistance gene-expression unit (see Figure  S1 in the Supplemental Data available with this article online). Exon 4 encodes residues 135-169, which are located in the center of the Dbl homology domain; thus, its deletion should result in the loss of the GEF activity. To validate this assumption, we expressed a P-Rex1 mutant form that lacks residues 135-169 and found that the P-Rex1 mutant was indeed unable to stimulate Rac1 activation in transfected 293 cells but that the wild-type P-Rex1 could (data not shown). The targeted P-Rex1 alleles in the mutant mice were confirmed by both Southern blot ( Figure S1 ) and PCR analyses (data not shown). RT-PCR analysis of P-Rex1 mRNA from neutrophils isolated from P-Rex1 mutant mice failed to detect RNA containing P-Rex1 exon 4 (data not shown), further confirming that the P-Rex1 gene has been successfully mutated. P-Rex-1 mutant mice appeared to develop normally and showed no apparent gross phenotypes under the specific pathogen-free housing condition.
P-Rex1 Inactivation Failed to Affect Chemoattractant-Induced Activation of Rac1
Previous in vitro results suggest that P-Rex1 may be an important GEF for Rac activation in mouse neutrophils [14] . Thus, we first examined if P-Rex1 inactivation affected Rac1 activation by fMLP, a potent neutrophil chemoattractant. To our surprise, mouse neutrophils isolated from P-Rex1 mutant mice responded almost as well as the wild-type neutrophils in Rac1 activation ( Figures 1A and 1B) . The active Rac1 levels were determined by the PBD pull-down assay, performed as previously described [6, 15] . This result suggests that P-Rex1 is not important for Rac1 activation in neutrophils.
P-Rex1 Deficiency Diminishes Rac2 Activation
Knowing that mouse neutrophils contain both Rac1 and Rac2 at about the same levels, we examined the effect of P-Rex1 deficiency on Rac2 activation by fMLP. Interestingly, P-Rex1 deficiency almost completely abolished fMLP-induced Rac2 activation ( Figure 1C ). This result suggests that P-Rex1 may have a preference for Rac2 over Rac1 and function as a predominant Rac2 GEF in mouse neutrophils. To understand the mechanistic basis for this preference for Rac2 over Rac1, we examined whether P-Rex1 has a higher affinity for Rac2 than Rac1. Previous studies have shown that GEFs have high affinities for nucleotide-depleted GTPases and that the S17N mutation in Rac molecules could mimic the nucleotide-depleted state and thus allow binding to Rac GEFs at high affinities [16, 17] . To compare the affinities of P-Rex1 for Rac1 S17N and Rac2 S17N , we expressed HA-Rac1 S17N at three different levels ( Figure 1D, lanes 2-4) , and HA-Rac2 S17N was expressed at a level in between the two lower levels of Rac1 S17N ( Figure 1D ; compare lane 5 with lanes 3 and 4). In addition, Myc-tagged P-Rex1 was coexpressed with the Rac molecules. When the Rac molecules were immunoprecipitated with an anti-HA antibody, we could only detect P-Rex1 in cells expressing the highest level of Rac1 S17N , but not in those expressing the levels that are similar to that of Rac2 S17N ( Figure 1D ). These results suggest that P-Rex1 may have a higher affinity for Rac2 than for Rac1. 
P-Rex1 Deficiency Results in a Partial
Reduction in Superoxide Production in Neutrophils P-Rex1 was also previously shown to have a significant role in the regulation of superoxide production [14] . Thus, we examined the effect of P-Rex1 deficiency on chemoattractant-induced production of superoxides in primary neutrophils. Bone marrow neutrophils isolated from both wild-type and P-Rex1 null mice were stimulated with fMLP, LPS, or PMA, and superoxide production was measured by the isoluminol-based chemiluminescence assay [18] . We found that P-Rex1 mutant neutrophils produced significantly fewer superoxide products than the wild-type neutrophils did (there was more than a 60% reduction; Figure 2A ). P-Rex1 deficiency, on the other hand, did not appear to significantly affect LPS or PMA-stimulated superoxide production ( Figures 2B and 2C ). Because endotoxin LPS and phorbal ester PMA stimulate superoxide production via different mechanisms than those used by chemoattractants, we conclude that P-Rex1 is primarily involved in chemoattractant-induced superoxide production. These results are consistent with the previous finding that P-Rex1 [14] and particularly Rac2, but not Rac1 [10-12, 19], have a significant role in the regulation of superoxide production in neutrophils.
P-Rex1 Mutant Neutrophils Are Defective in Chemotaxis
As Rac2 deficiency has been shown to cause defects in chemotaxis [9, 11, 12], we examined whether P-Rex1-deficiency affects neutrophil chemotaxis. We initially evaluated the role of P-Rex1 on chemotaxis by using the modified Boyden chamber assay. We observed an approximately 35% reduction in chemotactic indices for P-Rex-1 mutant neutrophils compared to the wildtype neutrophils ( Figure 3A) . The chemotaxis index is the ratio of the number of migrated neutrophils in the presence of chemoattractants to that in its absence. To further characterize the effect of P-Rex1 deficiency on neutrophil chemotaxis, we tracked individual cell migration by using a Dunn chemotaxis chamber and timelapse videomicroscopy. The Dunn chamber allows es- tablishment of a stable, shallow chemoattractant gradient and observation of cell migration in real time. We found that P-Rex1 mutant neutrophils still could sense and migrate along the chemoattractant gradient ( Figure  3B ; Movie S1 and Movie S2). Quantitative analysis of the directionality (percentage of cells moving toward the source of chemoattractant) revealed no differences between P-Rex1 mutant and wild-type neutrophils (Figure 3C) . However, when we examined the rate of cell migration, we found that P-Rex1 mutant neutrophils migrated significantly more slowly than the wild-type. This is evidenced by a 33% reduction in the overall translocation rate (Figure 3D) , which is the translocation distance of each tracked cell in 10 min in the chemoattractant gradient, and by the increases in the number of cells migrating at slower rates ( Figure 3E ) than those of the wild-type cells. Therefore, the chemotactic defects observed for the P-Rex-1 mutant neutrophils in the Boyden chamber assay may be due to the reduction in the migration rate rather than to the loss of directionality. This conclusion is further supported by the observation that P-Rex1 null neutrophils can polarize as well as wild-type cells but move more slowly even under uniform stimulation of a chemoattractant ( Figure S2 ). Because casein-induced recruitment of neutrophils to the peritonea showed a 25%-30% decrease in the number of P-Rex1 mutant mice compared to the wild-type mice ( Figure S3 ), it appears that P-Rex1 deficiency may also cause a cell-migration defect in vivo.
Because F actin formation provides primary driving force for neutrophil locomotion, the defect in motility rates of P-Rex1 null neutrophils suggests that there should be a defect in F actin formation. Thus, we examined fMLP-induced F actin formation and found that P-Rex1 defciency significantly attenuated the acute F actin formation at 15 s after ligand stimulation ( Figures  3F and 3G) .
In this study, we made an unanticipated observation that P-Rex1 is not the major Rac1 GEF but is instead a significant Rac2 GEF. This conclusion is further supported by the fact that the phenotypes observed with the P-Rex1 mutant neutrophils resemble more what was found with the Rac2 null neutrophils than with the Rac1 mutant neutrophils. Rac2 deficiency led to reduction in superoxide production, chemotaxis, and F actin formation [9-12], whereas Rac1 deficiency resulted in a defect in directionality of cell migration [13] . Thus, Rac1 and Rac2, which have been shown to regulate distinct cellular effects [9] [10] [11] , are also differentially regulated in mouse neutrophils. Although the precise mechanism for P-Rex1's preference for Rac2 over Rac1 is not known, this preference may be at least in part explained by the apparent higher affinity of P-Rex1 for the Rac2 S17N mutant. This higher Rac2 affinity observed in a precipitation assay may require modifications on P-Rex1 or Rac (less likely) or the presence of scaffold proteins because no significant preference of purified recombinant P-Rex-1 for purified recombinant Rac2 over Rac1 was observed (H. Welch, personal communication). The different regulation of downstream targets by the two Rac isoforms appears to lie in the difference in their C-terminal amino acid sequences [20] . It is not known if these sequences are also responsible for the difference in regulation by P-Rex1. It is also not known why the two Rac isoforms are regulated via different mechanisms given that they are both activated by chemoattractants. The difference in their regulation of downstream effectors may provide a rationale because cells may need to regulate different cell processes with varying dynamics and magnitudes.
Knowing that P-Rex1 deficiency fails to affect Rac1 activation in mouse neutrophils and that P-Rex2, the close homolog of P-Rex1, is not expressed in myeloid cells [21] , there have to be other mechanisms for Rac activation by chemoattractants. Although PIP3 may have a role in modulating Rac activation, PI3Kγ deficiency, which abrogates chemoattractant-induced pro- 
Immunoprecipitation and PBD Pull-Down Assay
Cells were lysed in the lysis buffer (5 mM HEPES [pH 7.4], 150 mM NaCl, 15 mM NaF, 2 mM EDTA, 1 mM EGTA, 10% glycerol, 1% Triton X-100, 20 mM β-glycerophosphate, 1 mM orthovanadate, 1 mM sodium pyrophosphate, 10 g/ml aprotinin, and 10 g/ml leupeptin). The cell lysates were subject to high-speed centrifugation. The supernatants were then incubated with an antibody and 20 l of protein A/G-Sepharose beads (Santa Cruz Biotech, CA) for 2 hr at 4°C. The immunocomplexes were pelleted and washed three times with cold lysis buffer in the absence of protease and phosphatase inhibitors. The proteins were released from beads by being boiled in SDS sample buffer. The samples were analyzed by Western blotting. The results were visualized with a Raytest imaging system with a cooled CCD camera. The PBD pull-down assay was carried out as described previously [6] .
Neutrophil Preparation and Stimulation
Murine bone marrow neutrophils were prepared by centrifugation through Percoll gradients. Purified neutrophils were suspended in Hanks' buffer (0.14 M NaCl, 5.4 mM KCl, 1 mM Tris, 1.1 mM CaCl 2 , 0.4 mM MgSO 4 , and 1 mM HEPES [pH 7.2]) containing 5 mg/ml BSA. For the modified Boyden chamber assay, 1,000,000 cells were loaded to the top chamber. Two hours later, the number of cells that had migrated to the bottom side of the membrane that separates the chambers were stained and counted. For the Dunn chemotaxis chamber assay, isolated neutrophils were allowed to adhere to glass coverslips for 5 min at 37°C. The coverslips were then rinsed and placed on the Dunn chamber for chemotaxis assays. Cell migration was recorded with time-lapse videomicroscopy. The microscope was equipped with differential interference contrast optics and a 20× objective. Images were captured at 5 s intervals with a PXL-EEV37 CCD camera (Photometrics, Waterloo, Ontario, Canada) and Metamorph imaging software (West Chester, PA). Time-lapse video images were used for tracing cell-migration track and calculating the final position of a cell relative to its starting position and migration rates. Time-lapse videomicroscopy data were also analyzed with the Metamorph software to determine migration parameters as described previously [28] .
Superoxide Assay
Murine neutrophil superoxide production was measured by isoluminol chemiluminescence assay [18, 28] . Isolated bone marrow neutrophils were suspended in Hank's buffer (Gibco) at 10 × 10 6 /ml on ice. Fifty microliters of cells were mixed with 40 l HRP (100U/ml) and 80 l isoluminol (125 M) in a well of a 96-well plate. FMLP (10 M), PMA (1 M), or LPS (10 g/ml) was used for stimulation, and chemiluminescence was detected by a luminometer. The assay was run in triplicate, and neutrophils from three P-Rex1 mutant mice and wild-type littermates were assayed in parallel. 
